A newly released study seeks to increase sickle cell disease detection and treatment rates in newborn babies across Nigeria through HemoTypeSC, a rapid diagnostic test.
Our journalism is only possible with support from you, our readers. The news mainstream media just doesn't cover. Racial justice journalism since 1909.
The news mainstream media just doesn't cover. Racial justice journalism since 1909.
We need you NOW! For 115 years we have delivered award winning racial justice journalism — and only with your support can we continue!
Digital Only
$6/month
Print & Digital
$8/month
Already a subscriber? Log in to hide this.
A newly released study seeks to increase sickle cell disease detection and treatment rates in newborn babies across Nigeria through HemoTypeSC, a rapid diagnostic test.